The largest database of trusted experimental protocols

Alzet 2001 osmotic minipumps

Manufactured by Durect
Sourced in United States

The Alzet 2001 osmotic minipump is a laboratory equipment designed for the continuous and controlled delivery of test substances in research studies. It operates using an osmotic mechanism to release the test substance at a constant rate over a predetermined duration, typically 1-4 weeks. The device is compact, lightweight, and can be implanted subcutaneously or intraperitoneally in small laboratory animals for long-term studies.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using alzet 2001 osmotic minipumps

1

Rat Implantation of Osmotic Minipumps

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, 20 male Dark Agouti rats (Harlan, Olac Ltd, Shaw's Farm, Blackthorn, Bicester, Oxon, UK, aged: 8 weeks, weighing 158±4 g [mean ± S.E.M.) were used. The animal experiments and housing conditions were carried out in accordance with the European Community Council Directive of 24 November 1986 (86/609/EEC), as well as the National Institutes of Health Principles of Laboratory Animal Care (NIH Publication 85-23, revised 1985) and special national laws (the Hungarian Governmental Regulation on animal studies, 31 December 1998 Act). The experiments were approved by the National Scientific Ethical Committee on Animal Experimentation and permitted by the Food Chain Safety and Animal Health Directorate of the Central Agricultural Office, Hungary (permission number: 22.1/3152/001/2007).
Prior to implantation, Alzet 2001 osmotic minipumps (Durect Corp., CA, USA) were filled with VLX dissolved in 0.9% NaCl solution.
+ Open protocol
+ Expand
2

MDMA Dosing and Administration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
(±)3,4-methylenedioxymethamphetamine (Sanofi-Synthelabo-Chinoin, Hungary, purity > 99.5%) was dissolved in 0.9% NaCl (SAL) at an equivalent dose of 15 mg/kg free base and was administered intraperitoneally (i.p.) in a volume of 1 ml/kg. The dose of MDMA was selected based on the interspecies scaling Dhuman=DanimalWhumanWanimal0.7 , where D are doses in mg and W are weights in kg [81 ]. By using Wanimal = 0.152 kg, Danimal = 15 mg/kg * 0.152 kg, and Whuman = 70 kg, our administration protocol results in a dose of 166.8 mg human dose [81 ] that is in a similar range as in a recent clinical study (187.5 mg) on MDMA’s therapeutic effects [25 (link)] and can be found in purer MDMA tablets for recreational use [2 (link), 82 (link)].
For control animals SAL was used i.p. in equivalent volumes (1 ml/kg). The MDMA-treated and control groups consisted of 11 and 10 animals, respectively, and were randomly assigned to each group. Vehicle-containing Alzet 2001 osmotic minipumps (Durect Corp., CA, USA) were inserted under the skin for all animals. The rats were sacrificed 3 weeks after the injections.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!